CD44 and prostate carcinoma: Activation of TGF-β signal expanded the CD44+CD24- population in prostate cancer cells through downregulating poly r(C) binding protein (PCBP)-1 (Chen et al., 2015), which suggested that TGF-β might regulate PCSC maintenance.